Bringing multiple micronutrient supplements to pregnant women in Takeo Province, Cambodia
Official title: Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia: A Mixed-Methods Assessment
Run by University of British Columbia · NCT07400796 · Data updated 2026-11-12
This project will see if giving pregnant women in Takeo Province MMS (multiple micronutrient supplements) can be delivered effectively through local health centers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 710 (estimated) |
| Sponsor | University of British Columbia Academic / other |
| Locations | 1 site (Phnom Penh) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | May 31, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | February 17, 2026 |
| Trial ID | NCT07400796 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are pregnant individuals aged 18 or older who have attended at least one antenatal care visit at a health center or hospital in Takeo Province, can provide a working phone number, and consent to participate.
✕Probably not a fit
Individuals with diagnosed anemia who require iron–folic acid instead of MMS, those without phone access, or those who withdraw consent are unlikely to benefit from this pilot.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project follows pregnant individuals in Takeo Province who receive antenatal MMS during a government pilot to inform potential national scale-up. The study uses the Intervention Scalability Assessment Tool (ISAT) to examine fidelity and adaptation, reach and acceptability, and delivery setting and workforce capacity. Data are collected from clinic records, participant phone follow-up, and implementation staff feedback during routine antenatal care visits. Findings will identify context-specific barriers and facilitators for integrating MMS into Cambodia's maternal health services.
Why it matters
Potential benefit: If successful, the project could help expand access to improved prenatal nutrition and reduce maternal and newborn complications linked to micronutrient deficiencies.
How similar studies have gone: Randomized trials and WHO guidance indicate MMS provides added benefits over iron–folic acid for maternal and neonatal outcomes, but large-scale health system implementation studies in low- and middle-income countries remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
For the cohort of pregnant individuals consuming MMS: Inclusion Criteria: * Current pregnant * At least 18 years of age * Have attended at least one ANC visit at a health center or hospital in Takeo during the study period * Can provide a functioning phone number for follow-up contact * Willingness to participate and provide consent Exclusion Criteria: * Individuals with diagnosed anemia who require iron and folic acid (IFA) supplementation instead of MMS * Individuals unable to communicate via telephone,;(3) individuals who withdraw consent at any point
Where it's running
-
Takeo province
Phnom Penh, Cambodia Recruiting
Study contacts
- Principal investigator: Crystal Karakochuk, PHD — University of British Columbia
- Study coordinator: Meng Sokchea Program Manager, Helen Keller International, MD
- Email: MSokchea@hki.org
- Phone: +855 023 213 217
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
DISC-0974-201 for adults with IBD-related anemia
This Phase 2 trial will test whether DISC-0974-201 helps adults with inflammatory bowel disease who have anemia driven by inflammation.
-
National registry for people with myelofibrosis and anemia in Germany.
This project will collect health, treatment, and quality-of-life information from people in Germany with primary or secondary myelofibrosis and anemia to see how their care and symptoms change over time.
-
Linking clinic and community digital records and local teams to boost antenatal clinic visits
This project will test whether linking facility and community digital health records and training local Work Improvement Teams to use those data increases antenatal clinic visits for pregnant women in Homa Bay County, Kenya.
-
Evaluating DISC-0974 for treating anemia in myelofibrosis patients
This study tests if a new treatment called DISC-0974 can help people with myelofibrosis who have anemia feel better and improve their condition.
-
A large cohort study on prenatal and early life factors affecting children's health in China
This study looks at how things like pregnancy and early feeding habits affect the health and growth of children in China.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.